HCA

$462.861.04%-4.87

Nachbörslich: 462.860.00 0.00%

Hca Healthcare Inc (HCA)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$467.73

Offen:

$463.72

24-Stunden-Volumen:

986,311

Relatives Volumen:

0.69

Marktkapitalisierung:

$96.69B

Einnahmen:

$76.39B

Nettoeinkommen (Verlust:

$7.81B

KGV:

15.92

EPS:

$29.08

Netto-Cashflow:

$7.93B

1W Leistung:

+2.87%

1M Leistung:

+8.48%

6M Leistung:

+6.87%

1Y Leistung:

+0.28%

1-Tages-Spanne:

$460.68$470.36

1-Wochen-Bereich:

$445.00$485.73

52-Wochen-Spanne:

$353.99$556.52

Hca Healthcare Inc Aktie (HCA) Unternehmensprofil

Firmenname

Hca Healthcare Inc

Sektor

Healthcare

Branche

Medical Care Facilities

Telefon

(615) 344-9551

Adresse

ONE PARK PLZ, NASHVILLE, TN, USA

Mitarbeiter

320,000

@hcahealthcare

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

HCA-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Hca Healthcare Inc Aktie (HCA) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-09-23	Eingeleitet	BMO Capital Markets	Outperform
2026-07-08	Herabstufung	Barclays	Overweight → Equal Weight
2025-12-15	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2025-10-14	Resumed	Goldman	Buy
2025-07-28	Herabstufung	Wolfe Research	Outperform → Peer Perform
2025-07-16	Herabstufung	BofA Securities	Buy → Neutral
2025-05-29	Hochstufung	Wells Fargo	Underweight → Equal Weight
2025-04-15	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-12-17	Resumed	JP Morgan	Neutral
2024-11-25	Herabstufung	Wells Fargo	Equal Weight → Underweight
2024-11-22	Herabstufung	Raymond James	Outperform → Mkt Perform
2024-10-11	Eingeleitet	KeyBanc Capital Markets	Overweight
2024-09-03	Eingeleitet	Morgan Stanley	Equal-Weight
2024-05-30	Eingeleitet	Robert W. Baird	Outperform
2024-03-06	Eingeleitet	Barclays	Overweight
2024-01-04	Herabstufung	Bernstein	Outperform → Mkt Perform
2023-12-11	Herabstufung	Goldman	Buy → Neutral
2023-04-21	Eingeleitet	Cantor Fitzgerald	Overweight
2023-04-19	Resumed	JP Morgan	Neutral
2022-07-06	Herabstufung	BMO Capital Markets	Market Perform → Underperform
2022-06-17	Eingeleitet	Loop Capital	Buy
2022-05-27	Hochstufung	Bernstein	Mkt Perform → Outperform
2022-03-29	Eingeleitet	Wells Fargo	Equal Weight
2022-01-10	Resumed	Citigroup	Buy
2021-12-21	Herabstufung	JP Morgan	Overweight → Neutral
2021-09-27	Eingeleitet	SVB Leerink	Outperform
2021-09-24	Eingeleitet	UBS	Buy
2021-09-10	Eingeleitet	Cowen	Outperform
2021-08-12	Herabstufung	Barclays	Overweight → Equal Weight
2021-07-09	Eingeleitet	Seaport Global Securities	Buy
2021-05-13	Resumed	Citigroup	Neutral
2021-04-26	Herabstufung	Citigroup	Buy → Neutral
2020-12-15	Eingeleitet	Goldman	Buy
2020-12-14	Hochstufung	JP Morgan	Neutral → Overweight
2020-09-21	Herabstufung	JP Morgan	Overweight → Neutral
2020-07-13	Herabstufung	BMO Capital Markets	Outperform → Market Perform
2019-09-06	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-07-10	Hochstufung	Goldman	Neutral → Buy
2019-04-23	Hochstufung	Raymond James	Mkt Perform → Outperform
2019-01-14	Eingeleitet	Stephens	Overweight
2019-01-03	Eingeleitet	Deutsche Bank	Buy
2018-11-16	Eingeleitet	UBS	Buy
2018-03-23	Resumed	Mizuho	Buy
2018-01-03	Eingeleitet	Goldman	Neutral
2018-01-03	Herabstufung	Piper Jaffray	Overweight → Neutral
2017-12-20	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2017-12-12	Hochstufung	Citigroup	Neutral → Buy
2017-11-30	Hochstufung	JP Morgan	Neutral → Overweight
2017-11-06	Bestätigt	Citigroup	Neutral
2017-11-01	Bestätigt	Mizuho	Buy
2017-07-26	Herabstufung	BofA/Merrill	Buy → Neutral
2017-06-28	Eingeleitet	Argus	Buy

Finanzdaten der Hca Healthcare Inc-Aktie (HCA)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	75,600.00	70,603.00	64,968.00	60,233.00	58,752.00
Operating expenses USD (M)	65,768.00	62,080.00	57,262.00	51,653.00	48,919.00
Operating income USD (M)	-	-	7,706.00	8,580.00	9,833.00
Income before tax USD (M)	9,832.00	8,523.00	7,706.00	8,580.00	9,833.00
Income tax expense USD (M)	2,050.00	1,866.00	1,615.00	1,746.00	2,112.00
Net income USD (M)	7,782.00	6,657.00	6,091.00	6,834.00	7,721.00
Basic EPS USD/shares	28.70	22.27	19.25	19.43	21.52
Diluted EPS USD/shares	28.33	22.00	18.97	19.15	21.16
Basic weighted shares shares (M)	236.41	258.60	272.40	290.35	323.32
Diluted weighted shares shares (M)	239.50	261.81	276.41	294.67	328.75

Hca Healthcare Inc-Aktie (HCA) Insiderhandel

Michael S CuffeOct 29 '26
Officer
Transaktion
Proposed Sale
Kosten
$477.00
#Aktien
11,800
Wert ($)
5,628,600
#Aktien Gesamt
0
Schlosser Michael JOct 29 '26
EVP and Chief Clinical Officer
Transaktion
Option Exercise
Kosten
$82.30
#Aktien
4,928
Wert ($)
405,588
#Aktien Gesamt
5,098
McAlevey Michael RFeb 18 '26
EVP & Chief Legal & Admin Off.
Transaktion
Sale
Kosten
$533.37
#Aktien
1,694
Wert ($)
903,537
#Aktien Gesamt
8,853
Michael R McAleveyFeb 18 '26
OFFICER
Transaktion
Proposed Sale
Kosten
$533.34
#Aktien
1,694
Wert ($)
903,486
#Aktien Gesamt
0
McAlevey Michael RFeb 13 '26
EVP & Chief Legal & Admin Off.
Transaktion
Option Exercise
Kosten
$236.61
#Aktien
5,000
Wert ($)
1,183,050
#Aktien Gesamt
13,853
Jennifer L. BerresFeb 11 '26
OFFICER
Transaktion
Proposed Sale
Kosten
$514.58
#Aktien
8,020
Wert ($)
4,126,950
#Aktien Gesamt
0
Berres JenniferFeb 11 '26
SVP & Chief Human Res. Officer
Transaktion
Sale
Kosten
$514.58
#Aktien
8,020
Wert ($)
4,126,950
#Aktien Gesamt
11,993
Wyatt Christopher F.Feb 11 '26
SVP & Controller
Transaktion
Sale
Kosten
$505.00
#Aktien
4,000
Wert ($)
2,020,000
#Aktien Gesamt
44,379
Foster Jon MFeb 05 '26
EVP and COO
Transaktion
Option Exercise
Kosten
$139.06
#Aktien
29,330
Wert ($)
4,078,630
#Aktien Gesamt
29,330
Wyatt Christopher F.Feb 05 '26
SVP & Controller
Transaktion
Option Exercise
Kosten
$139.06
#Aktien
10,670
Wert ($)
1,483,770
#Aktien Gesamt
51,737

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Michael S Cuffe	Officer	Oct 29 '26	Proposed Sale	$477.00	11,800	5,628,600	0
Schlosser Michael J	EVP and Chief Clinical Officer	Oct 29 '26	Option Exercise	$82.30	4,928	405,588	5,098
McAlevey Michael R	EVP & Chief Legal & Admin Off.	Feb 18 '26	Sale	$533.37	1,694	903,537	8,853
Michael R McAlevey	OFFICER	Feb 18 '26	Proposed Sale	$533.34	1,694	903,486	0
McAlevey Michael R	EVP & Chief Legal & Admin Off.	Feb 13 '26	Option Exercise	$236.61	5,000	1,183,050	13,853
Jennifer L. Berres	OFFICER	Feb 11 '26	Proposed Sale	$514.58	8,020	4,126,950	0
Berres Jennifer	SVP & Chief Human Res. Officer	Feb 11 '26	Sale	$514.58	8,020	4,126,950	11,993
Wyatt Christopher F.	SVP & Controller	Feb 11 '26	Sale	$505.00	4,000	2,020,000	44,379
Foster Jon M	EVP and COO	Feb 05 '26	Option Exercise	$139.06	29,330	4,078,630	29,330
Wyatt Christopher F.	SVP & Controller	Feb 05 '26	Option Exercise	$139.06	10,670	1,483,770	51,737

Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten

Nov 02, 2026

Here’s How Much You Would Have Made Owning HCA Healthcare Stock In The Last 15 Years - Benzinga

Nov 02, 2026

HCA Healthcare Plans Senior Notes Offering Amid Strategic Debt M - GuruFocus

Nov 02, 2026

Form 4 HCA Healthcare, Inc For: 2 November By Investing.com - Investing.com Canada

Nov 02, 2026

HCA Healthcare subsidiary plans senior notes offering - Investing.com

Nov 02, 2026

Wells Fargo Adjusts Price Target on HCA Healthcare to $468 From $381 - marketscreener.com

Nov 02, 2026

Oct 30, 2026

HCA Q3 deep dive: payer mix shifts and resiliency initiatives shape outlook - Yahoo Finance

Oct 30, 2026

HCA Healthcare Data Breach Impacts Patients and Employees - Claim Depot

Oct 30, 2026

HCA Healthcare Inc. stock underperforms Friday when compared to competitors - MarketWatch

Oct 30, 2026

HCA Healthcare Lobbies on Hospital Price Transparency Measures - Legis1

Oct 30, 2026

Oct 29, 2026

HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 29, 2026

HCA Healthcare Inc Stock (HCA) Moved Up by 3.07% on Oct 29: What Investors Need To Know - TradingKey

Oct 29, 2026

THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised - Zacks Investment Research

Oct 29, 2026

The 5 most interesting analyst questions from HCA Healthcare’s Q3 earnings call - Yahoo Finance

Oct 29, 2026

More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care - Business Wire

Oct 29, 2026

HCA Healthcare Reports Third Quarter 2026 Results - Florida Hospital News and Healthcare Report

Oct 29, 2026

Oct 28, 2026

HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 28, 2026

HCA Healthcare Inc Stock (HCA) Moved Up by 3.18% on Oct 28: What Investors Need To Know - TradingKey

Oct 28, 2026

HCA’s bottom line suffers as ACA coverage losses mount - Healthcare Dive

Oct 28, 2026

HCA Healthcare: Payer Mix Pressures, But Broad Trends On Track (NYSE:HCA) - Seeking Alpha

Oct 28, 2026

HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results - Benzinga

Oct 28, 2026

HCA Healthcare (HCA) Stock Dips After Q3 Earnings Expose Margin Strain - Yahoo Finance

Oct 28, 2026

Oct. 28 - HCA Healthcare, Inc., owner of Memorial Health Hospital posts Revenue Decline - Savannah Business Journal

Oct 28, 2026

Oct 27, 2026